A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
[1] This means patients can use any of the approved sites without needing to adjust their dose or timing
Not available in all 50 US states
Same-day prescription approval Perfect medication packaging and shipping No video visit or lab work required Monthly check-ins prevent auto-billing Easy one-button cancellation in portal Claims 503B pharmacies but uses 503A Pricing only shown after completing intake No provider info shared, even when asked Meta ads show only lowest bundle price BBB rating of C with 18 complaints BEFORE WE DIG IN How IVY RX works + is it right for you
Fragmented offerings are being replaced by full-circle solutions across wellness, fitness, and healthcare sectors
Protein shakes can be an especially good option since they are already partially broken down and move through the stomach more easily